Investor Insights

This summary was created by AI, based on 2 opinions in the last 12 months.

Coloplast A/S (CLPBY-OTC) is a global leader in ostomy care, continence care, and wound care. Despite a dip in prices in 2022, the company has shown robust organic growth. With a strong dividend yield and high growth potential, it has caught the attention of investors. Two major acquisitions and a focus on M&A and R&D should drive future growth. Analysts have varying opinions on the stock, but overall, Coloplast presents a strong case for investment.

Consensus
Hold
Valuation
Fair Value
Similar
ConvaTec Group, CNVGY-OTC
TOP PICK
Coloplast A/S
Price target: 870.17 Danish krowns

Prices fell hard in 2022, but has partially come back as underlying growth has been robust at 8-9% organic growth in revenue per year. It pays a 2.3% dividend and offers high growth. Are the leaders in their space.

Healthcare
TOP PICK
Coloplast A/S

It is a Danish company which is a global leader in ostomy care and continence care, and third largest in wound care. It has done two big acquisitions. It has had some weakness in 2023 but should grow through good M&A and good R&D. It has had an 11% dividend growth rate per year and 12% share growth rate per year.       Buy 9  Hold 15  Sell 3

(Analysts’ price target is $841.23)
Healthcare
TOP PICK
Coloplast A/S
Makes catheters and colostomy bags. Elective surgeries are coming back. During pandemic, these were paused and medical device companies suffered. Their balance sheet is pristine. Number one in their business. Generate ROC close to 38%. Cost of capital is 6%. Room for R&D to move forward.
Healthcare
BUY ON WEAKNESS
Coloplast A/S
Targeting the aging demographic. Challenge has always been its expensive valuation. If it ever goes on sale, he'd probably buy it. You never go bankrupt taking a profit. A great company.
Healthcare
PAST TOP PICK
Coloplast A/S
(A Top Pick Jan 13/20, Up 21%) A Danish company specializing in incontinence and other medical products. A good defensive holding. They are expecting to cut revenues by 4-6%, but their margins are remaining strong as they commit to cut costs.
Healthcare
TOP PICK
Coloplast A/S
A Danish healthcare company that focuses on wound care, skin care, digestion and other areas. Smart managers continue to focus on R&D--he likes that. Since 2015, they've increased clinical studies by 2.5x and patents by 10x. They've spent free cash flow very well. Revenues have grown 9% annually even during the Great Recession. (Analysts’ price target is $10.74)
Healthcare
PAST TOP PICK
Coloplast A/S

(A Top Pick August 21/17, Up 24%) Colostomy bags and catheters, playing the aging demographic. Gained market share in US. Free cash flow is above competitors. Dividend grows about 10-15% per year. Investors go here to hide, so it goes up when markets go down. Buy on a pullback.

Healthcare
TOP PICK
Coloplast A/S

Colostomy bags. The demographics are such that gastrointestinal disorders are among the bigger problems dealing with the retirees of the world. If you get a company this size growing this fast without acquisitions you have a good company. They have a history of dividend increases. (Analysts’ target: DKK 553.00).

Healthcare
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »

Coloplast A/S(CLPBY-OTC) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Coloplast A/S is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Coloplast A/S(CLPBY-OTC) Frequently Asked Questions

What is Coloplast A/S stock symbol?

Coloplast A/S is a American stock, trading under the symbol CLPBY-OTC on the US OTC (CLPBY). It is usually referred to as OTC:CLPBY or CLPBY-OTC

Is Coloplast A/S a buy or a sell?

In the last year, there was no coverage of Coloplast A/S published on Stockchase.

Is Coloplast A/S a good investment or a top pick?

Coloplast A/S was recommended as a Top Pick by on . Read the latest stock experts ratings for Coloplast A/S.

Why is Coloplast A/S stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Coloplast A/S worth watching?

0 stock analysts on Stockchase covered Coloplast A/S In the last year. It is a trending stock that is worth watching.

What is Coloplast A/S stock price?

On 2024-03-27, Coloplast A/S (CLPBY-OTC) stock closed at a price of $13.55.